Shinichi Koizumi
Direktor/Vorstandsmitglied bei TSUBOTA LABORATORY INCORPORATED
Profil
Shinichi Koizumi is currently the Director, Vice President & CSO at AskAt, Inc. He is also an Independent Outside Director at Tsubota Laboratory, Inc. In the past, he served as the Executive Vice President at RaQualia Pharma, Inc. Dr. Koizumi holds a doctorate degree from Tokyo Institute of Technology, which he obtained in 1986.
Aktive Positionen von Shinichi Koizumi
| Unternehmen | Position | Beginn |
|---|---|---|
| TSUBOTA LABORATORY INCORPORATED | Direktor/Vorstandsmitglied | 01.06.2020 |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
Ehemalige bekannte Positionen von Shinichi Koizumi
| Unternehmen | Position | Ende |
|---|---|---|
| RAQUALIA PHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.11.2012 |
Ausbildung von Shinichi Koizumi
| Tokyo Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| TSUBOTA LABORATORY INCORPORATED | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
